America allows the use of weight loss pills

The US Food and Drug Administration (FDA) has approved the first tablet version of a popular anti-obesity treatment that helps lose weight, according to what was revealed by the Danish pharmaceutical laboratory “Novo Nordisk” that developed the treatment..

This decision would facilitate access in the United States to these very popular weight loss treatments, which are considered highly advanced in their field in the opinion of experts..

This technology, which was initially developed to treat diabetes, helps mimic the action of the gastrointestinal hormone GLP-1, which regulates appetite, and is commercialized in the context of the drugs Ozambik, Wegovi, and Zibound.

It is usually available in the form of an injectable solution, but is now being developed in pill form to make it easier to take.

Novo Nordisk indicated in its statement that “Wegovy pills” are “the first… oral GLP-1 hormone treatment approved for weight control” in the United States..

US health authorities have previously approved another pill version of these widely used treatments, but not for weight loss.

These treatments, which allow significant weight loss, have seen great demand in recent years, especially in the United States, where obesity, which is a chronic disease, affects about 40% of adults..

However, it is not within the reach of a large number of patients due to its high price, which may exceed a thousand dollars per month.